Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The M2 proton channel protein is an integral membrane protein found in the viral envelope of the influenza A virus. It functions as a pH-activated, proton-selective ion channel essential for viral replication and infectivity. It transports protons from acidic endosomes into the interior of the virion after endocytosis, leading to dissociation of matrix proteins from ribonucleoprotein complexes, enabling release of viral RNA into host cell cytoplasm for replication. The M2 channel is targeted by antiviral drugs such as amantadine and rimantadine that block its activity, however, resistance mutations are now widespread among circulating influenza strains.
M2 channel inhibitors block the proton channel, preventing proton influx into the virion and inhibiting viral uncoating.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on M2 Proton Channel Protein (M2).